ArticleslgStudy

science

M72/AS01E

M72/AS01E is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand M72/AS01E rather than just read about it. In short: M72/AS01E is an experimental tuberculosis vaccine. If approved, it would be the first vaccine for tuberculosis in more than a century after the BCG vaccine.

Key takeaways

  • M72/AS01E belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect M72/AS01E to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of M72/AS01E from memory before moving on to harder problems.

Reference excerpt

M72/AS01E is an experimental tuberculosis vaccine. If approved, it would be the first vaccine for tuberculosis in more than a century after the BCG vaccine. The vaccine consists of two main ingredients. The antigen part is M72, a recombinant fusion protein derived from the sequences of two M. tuberculosis antigens (Mtb32A O07175 and Mtb39A L7N675). The adjuvant part is AS01E, a combination of QS-21, cholesterol, and monophosphoryl lipid A (MPL). It was initially developed by GSK plc and funded by non-profits and governments due to the limited commercial potential of tuberculosis vaccines, which are mainly needed in poor countries. The vaccine candidate completed a Phase II clinical trial in 2018, but its development was stalled thereafter due to negotiations between GSK, which was uninterested in the late stage development of the vaccine candidate, and non-commercial backers. After almost two years, the company concluded an agreement with the Bill & Melinda Gates Medical Research Institute. The Phase III trial is funded by the Wellcome Trust (up to US$150 million) and the Gates Foundation (the remaining around US$400 million). It is scheduled to begin in 2024 with results available in 2028. One issue in developing the vaccine is the need for QS-21 bark extract from the tree Quillaja saponaria that is used in combination with monophosphoryl lipid A as an immunologic adjuvant. This adjuvant is used by several other GSK vaccines—especially the shingles vaccine that is more profitable—and GSK owns most of the world's supply.

References

Worked examples

Example 1 — a first encounter with M72/AS01E

Start with the simplest possible case. Write down what M72/AS01E claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to M72/AS01E before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about M72/AS01E ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of M72/AS01E

In research
M72/AS01E appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses M72/AS01E in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
M72/AS01E is common in secondary-school and first-year university syllabi. It links to neighbouring topics Drugs developed by GSK plc, Tuberculosis vaccines, so understanding it makes those chapters shorter.
In everyday life
Look for M72/AS01E outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “M72/AS01E” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study M72/AS01E in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what M72/AS01E means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain M72/AS01E out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is M72/AS01E in simple terms?

M72/AS01E is an experimental tuberculosis vaccine. If approved, it would be the first vaccine for tuberculosis in more than a century after the BCG vaccine.

Why does M72/AS01E matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study M72/AS01E?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on M72/AS01E.

Tags

  • Drugs developed by GSK plc
  • Tuberculosis vaccines

Keep exploring